Citation Impact
Citing Papers
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Association of trial registration with the results and conclusions of published trials of new oncology drugs
2009
Evaluation of networks of randomized trials
2007
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
2021 Standout
Predictors of outcome in early onset schizophrenia: a 10-year follow-up study
2020
International Consensus Study of Antipsychotic Dosing
2010
Shared Decision Making: A Model for Clinical Practice
2012 Standout
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Schizophrenia: an integrated sociodevelopmental-cognitive model
2013
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications
2011
Relationship between drug company funding and outcomes of clinical psychiatric research
2006
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
2008
The behaviour change wheel: A new method for characterising and designing behaviour change interventions
2011 Standout
Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor
2015
Schizophrenia
2009 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences
2010
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
2009
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered
2009
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
2008
Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database
2012
A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
2014
Factors Associated with Results and Conclusions of Trials of Thiazolidinediones
2009
Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
2006 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
How to read and understand and use systematic reviews and meta‐analyses
2009
Duration of untreated psychosis and negative symptoms — A systematic review and meta-analysis of individual patient data
2012
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Industry sponsorship and selection of comparators in randomized clinical trials
2009
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
2007
Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry
2011
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia
2007
Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Neglected tropical diseases: survey and geometry of randomised evidence
2012
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
Reporting bias in medical research - a narrative review
2010
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions.
2007 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Issues that May Determine the Outcome of Antipsychotic Trials: Industry Sponsorship and Extrapyramidal Side Effect
2007
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
How should meta‐regression analyses be undertaken and interpreted?
2002 Standout
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
2013
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review
2011 Standout
What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies
2014 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Industry sponsorship and research outcome
2012 Standout
Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments
2011
Enhanced predictive signalling in schizophrenia
2017
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Exploring the Geometry of Treatment Networks
2008
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Interventions for providers to promote a patient-centred approach in clinical consultations
2012 Standout
Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
2012
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Cooling for newborns with hypoxic ischaemic encephalopathy
2013 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Risperidone versus other atypical antipsychotics for schizophrenia
2011
From optimism to disillusion about commitment to transparency in the medico-industrial complex
2006
Pavlovian conditioning–induced hallucinations result from overweighting of perceptual priors
2017 StandoutScience
Geometry of the Randomized Evidence for Treatments of Pulmonary Hypertension
2013
Mobile phone messaging reminders for attendance at healthcare appointments
2013 Standout
Interprofessional education: effects on professional practice and healthcare outcomes
2013 Standout
Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
2014
From Optimism to Disillusion about Commitment to Transparency in the Medico-Industrial Complex
2006
Improving outcomes of first‐episode psychosis: an overview
2017
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Interventions for preventing falls in older people living in the community
2012 Standout
Industry sponsorship and research outcome
2017 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Works of Stephan Heres being referenced
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
2016
Language bias in neuroscience—is the Tower of Babel located in Germany?
2004
Evidence-based pharmacotherapy of schizophrenia
2011
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
2009
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
2012